Diversigen, a portfolio company of Baylor College of Medicine, has been sold to OraSure Technologies

Client: Baylor College of Medicine

Client Location: United States

Target: Diversigen, Inc.

Target Location: United States

Buyer: OraSure Technologies (NASDAQ:OSUR)

Buyer Location: United States

Target Description: Diversigen is a leading provider of comprehensive, integrated and multidimensional insights into the diverse microbiomes of living organisms and environments.

Diversigen Baylor College Of Medicine Orasure Technologies 2019
  • 2019
    Close Year
  • Healthcare
    Industry
  • Private
    Client Type
  • Strategic | Domestic
    Transaction Type
  • USA
    Country

Meet our Senior Team

Any information or testimonials contained in this post may not be representative of the experience of other clients and is no guarantee of future performance or success.